Updates are available Correction dated 2021-12-08
Click to view Correction: https://doi.org/10.1007/s10875-021-01180-7
-
Authors
Consiglieri, Giulia
Ferrua, Francesca
Brianti, Pina
Peccatori, Jacopo
Markel, Sarah
Giglio, Fabio
Ladogana, Saverio
Notarangelo, Lucia Dora
Bernardo, Maria Ester
Ciceri, Fabio
Bognanni, Antonio
Migliavacca, Maddalena
Barzaghi, Federica
Calbi, Valeria
Tucci, Francesca
Gallo, Vera
Dionisio, Francesca
Giannelli, Stefania
Cenciarelli, Sabina
Ciotti, Francesca
Fraschetta, Federico
Casiraghi, Miriam
Paolino, Giovanni
Mercuri, Santo Raffaele
Aiuti, Alessandro http://orcid.org/0000-0002-5398-1717
Cicalese, Maria Pia
,
- License Information
-
More Information
Article History
Received: 1 July 2021
Accepted: 11 October 2021
First Online: 4 November 2021
Change Date: 8 December 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s10875-021-01180-7
Declarations
:
: The compassionate use program was approved by the independent ethics committee of the San Raffaele Scientific Institute and the Italian regulatory authority (Agenzia Italiana del Farmaco [AIFA]).
: Informed consent was obtained from all individual participants included in the study.
: Patients signed informed consent regarding publishing their data and photographs.
: A. Aiuti declares the role of principal investigator of the TIGET-WAS clinical trial sponsored by Orchard Therapeutics. The rest of the authors declare that they have no relevant conflicts of interest.
